Sotatercept Improves Anemia, Vascular Calcification, and Bone Loss in Patients With End-Stage Kidney Disease on Hemodialysis

Authors

John Havill, Kidney Specialists of Southern Nevada, Las Vegas, NV
Nelson Kopyt DO, FASN, FACP, Lehigh Valley Health NetworkFollow
Daniel Coyne, Washington University, St Louis, MO
Michael Weiswasser, Celgene Corporation, Warren, NJ
William T. Smith, Celgene Corporation, Warren, NJ

Publication/Presentation Date

11-3-2015

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Havill, J., Kopyt, N., Coyne, D., & Weiswasser, M., Smith, W. (2015, November 3). Sotatercept Improves Anemia, Vascular Calcification, and Bone Loss in Patients With End-Stage Kidney Disease on Hemodialysis. Poster presented at: ASN Kidney Week, San Diego, CA.

Disciplines

Medical Sciences | Medicine and Health Sciences | Nephrology

Department(s)

Department of Medicine, Department of Medicine Faculty, USF-LVHN SELECT Program, USF-LVHN SELECT Program Faculty

Document Type

Poster